1 result(s) displayed (1 - 1 of 1):
With big pharmaceutical companies looking to load their pipelines and biotechnology firms looking for capital to keep afloat, licensing deals between the two are a mainstay of the industry. And as such, not every deal gets a mention here. But a transaction announced Tuesday involving Novavex Inc. (NASDAQ:NVAX) and the...
Posted on July 1, 2009 9:40 AM
Movable Type search results powered by Fast Search